Literature DB >> 8097556

Mutants with substitutions for Glu171 in the catabolite activator protein (CAP) of Escherichia coli activate transcription from the lac promoter.

A Breul1, H Assmann, R Golz, B von Wilcken-Bergmann, B Müller-Hill.   

Abstract

Single amino acid substitutions for residue Glu171 in helix E of the catabolite gene activator protein (CAP) of Escherichia coli have been reported to abolish activation of transcription without impairing binding to the CAP site of the lac promoter. The negative charge of Glu171 was proposed to transmit the activating signal from CAP to RNA polymerase. However, this idea has been challenged by later work. We set up a system to re-examine this issue. We analysed the ability of mutant CAP-E171L and CAP-E171K proteins to bind a near-consensus CAP site in vivo and found it to be diminished fourfold relative to wild type in each case. Activation of lac transcription by these mutant proteins remains the same as with wild-type CAP. Thus our results confirm that Glu171 in helix E of CAP is not involved directly in the activation of transcription. Yet CAP-E171K does not activate transcription as well as wild-type CAP under all circumstances. Possible reasons for this absence of activation are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097556     DOI: 10.1007/bf00279542

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  25 in total

1.  Catabolite gene activator protein (CAP) is not an "acidic activating region" transcription activator protein. Negatively charged amino acids of CAP that are solvent-accessible in the CAP-DNA complex play no role in transcription activation at the lac promoter.

Authors:  X Zhang; Y Zhou; Y W Ebright; R H Ebright
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

2.  RNA polymerase bound to the PR promoter of bacteriophage lambda inhibits open complex formation at the divergently transcribed PRM promoter. Implications for an indirect mechanism of transcriptional activation by lambda repressor.

Authors:  P A Hershberger; P L deHaseth
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

3.  Identification of a contact between arginine-180 of the catabolite gene activator protein (CAP) and base pair 5 of the DNA site in the CAP-DNA complex.

Authors:  X P Zhang; R H Ebright
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  A simple method for site-directed mutagenesis using the polymerase chain reaction.

Authors:  A Hemsley; N Arnheim; M D Toney; G Cortopassi; D J Galas
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

5.  The effect of a lambda repressor mutation on the activation of transcription initiation from the lambda PRM promoter.

Authors:  D K Hawley; W R McClure
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

Review 6.  Cyclic AMP receptor protein: role in transcription activation.

Authors:  B de Crombrugghe; S Busby; H Buc
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

7.  Consensus DNA site for the Escherichia coli catabolite gene activator protein (CAP): CAP exhibits a 450-fold higher affinity for the consensus DNA site than for the E. coli lac DNA site.

Authors:  R H Ebright; Y W Ebright; A Gunasekera
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

8.  Model of specific complex between catabolite gene activator protein and B-DNA suggested by electrostatic complementarity.

Authors:  I T Weber; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  How Trp repressor binds to its operator.

Authors:  D Staacke; B Walter; B Kisters-Woike; B von Wilcken-Bergmann; B Müller-Hill
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Mutations in TrpI binding site II that differentially affect activation of the trpBA promoter of Pseudomonas aeruginosa.

Authors:  J Gao; G N Gussin
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.